Moderate riskFDA DrugClass II

Sun Pharmaceutical Carbamazepine 200mg tablets recalled for manufacturing defect

Sun Pharmaceutical's Carbamazepine 200mg tablets (Lot #AD94033, expiring 5/31/2028) contain black spots caused by burnt ingredients during manufacturing. The tablets do not meet quality standards, though no injuries have been reported.

From the FDA notice · Read the official notice ↗ · All Sun Pharmaceutical recalls

What to do

  1. Check if you have Carbamazepine tablets from Lot #AD94033 (expiring 5/31/2028).
  2. Do not stop taking your medication without talking to your doctor or pharmacist first.
  3. Contact your pharmacy or doctor for a replacement or alternative.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC 51672-4005-3.
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
1968 Bottles (1000Tablets/Bottle)
Illnesses reported
None reported
Manufactured in
2 Independence Way, Princeton, NJ, United States
Classification
Class II
Recall number
D-0770-2026

In the FDA's words

Description
Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC 51672-4005-3. CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing Lot # AD94033, Exp Date: 5/31/2028. Distribution: US Nationwide. Affected quantity: 1968 Bottles (1000Tablets/Bottle)
Hazard
CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing

More from Sun Pharmaceutical

See all

Related topics

OtherParticulateDrugsSold nationwideMore from FDA Drug